Search
NHS offers new drug to stop children and teens losing hearing after chemotherapy
- OPACC
- Jan 30
- 1 min read
Our SIOPEL-6 study showed that sodium thiosulfate (Pedmarqsi) almost halves the percentage of children and teenagers who lose hearing as a side effect of the platinum-based chemotherapy drug cisplatin.
Recent Posts
See AllA team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Comments